Domestic Teams Chime in on AMGEN Tour of California Success
USA Cycling domestic calendar continues to struggle with races coming and going, while staples such as the Tour of the Gila, struggle each year to continue. Heading into the final day of the 11th edition of the AMGEN Tour of California, USCR spoke with several directors and riders from the domestic peloton to ask about the significance of the race having lost the USA Pro Cycling Challenge this year.
Mark Cavendish wins final stage of 2016 Amgen Tour of California. Photo by Danny Heilprin
Team Novo Nordisk is competing in their third consecutive AMGEN Tour of California this week. Heading into the final two days of racing, the team’s best placed rider is veteran, Javier Megias, siting 16th on GC.
Originally named, Team Type 1, the team was founded in 2008. Novo Nordisk came on board in 2012, when the squad switched to an all-type 1 diabetes roster. The mission continues to be one of inspiration and education, working with Novo Nordisk to learn what is possible and how to manage diabetes for athletes.
USCR spoke with CEO and Co-Founder of the team, Phil Southerland, before the start in South Pasadena earlier this week about the team’s goals and aspirations for the rest of the season.
USCR's Rebecca Reza talks with Team Novo Nordisk' Phil Southerland.
The women took the line to contest the second stage of racing at the 2016 AMGEN Team Time Trial. A very exciting day in which the fans could watch the women race. Afterwards, Kristin Armstrong, Twenty16 – Ridebiker (on the team’s winning performance today) “We’re a unique team. We each bring something to the table, a different strength. Every team member gave it everything they had, and we took advantage of that piece of the course for every rider.”Megan Guarnier, Boels-Dolmans Cycling Team (on leading the GC) “I’m excited. I’m proud. It’s a team effort. The girls set me up for the win yesterday too, so it’s on my back, but it’s the whole team’s victory.”
Rohan Dennis Blazes to Stage Win and Second Overall - AlaPhilippe Turns In Inspired Folsom Time Trial to Cling to Race Lead
TWENTY16 – RIDEBIKER Captures Team Time Trial With US National TT Champ Kristin Armstrong Hard on Heels of Race Leader Megan Guarnier
The name of the game was “fast” in Folsom today as the 140 men competing in the 2016 Amgen Tour of Californiaraced the clock in their individual time trial event, with Australian Rohan Dennis (BMC Racing Team) recording the fastest time. Eighteen women’s teams in the Amgen Breakaway from Heart Disease™ Women’s Race Empowered with SRAM faced of for the race’s first-ever team time trial, with TWENTY16 – Ridebiker ending the day on top.
Women Power onto TTT Podium in Women’s Tour of California Stage 2
The women of the UnitedHealthcare Pro Cycling Team showed their combined strength with a podium result in the stage 2 team time trial at the 2016 Breakaway from Heart Disease Women’s Tour of California. The women and men shared the same 20.3-kilometer course starting and finishing in downtown Folsom. Heading north from the city center to Folsom Lake then tracing the shoreline east, the course took in just 484 meters of climbing, allowing the women to cruise along in tight formation at top speed, posting the third-fastest time of the day in a field stacked with Women's World Tour squads. Director Rachel Heal commented, “We have a tight-knit group of powerful riders here in California, and that showed in their ability to ride with precision and power. We’re happy to lock in a podium performance before the road stage in Santa Rosa.” The men raced the course individually shortly after the women, with Daniel Eaton and Jonny Clarke both clocking finishing times within three minutes of the stage winner.